The E In ESG: Does PVC Have A Future In Health Care’s Circular Economy?
Compatibility Of The Polymer’s Use With Green Aims Is Hotly Debated
Executive Summary
PVC, the most used polymer in the manufacture of single-use medical devices, has always been a target for the environmental lobby. The rise of the green agenda has heightened sensitivities further still. Europe’s PVC MedAlliance aims to show how the substance can fit into sustainability programs.
You may also be interested in...
The E in ESG: Consumer Health Compliance Will Not Be Optional For Much Longer
European consumer health companies have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from retailers and consumers mounting, compliance with mandatory standards is on the horizon, says Haleon’s sustainability chief Joe Muscat.
The E in ESG: Beware Green Claims That Might Backfire
Health care companies making carbon neutrality claims must tread a careful line while ensuring full accountability. CMS Vienna partner Gabriela Staber points to some of the risks businesses should be aware of when making sustainability claims.
Putting The E In ESG: A Global Medtech’s Approach To Meeting The Climate Challenge
The pressures on global medtechs to focus more on sustainability are internal as well as external. Scope 3 adds yet another layer of compliance. Johnson & Johnson’s EMEA VP for Surgical Vision Erin McEachren explains to In Vivo how her organization meets these challenges while simultaneously addressing EU Medical Device Regulation requirements and ensuring patient safety standards.